Articles

Editorial on the contribution of V. Labarque, entitled “New and emergent treatment options in sickle cell disease”

BJH - volume 12, issue 7, november 2021

P. Zachée MD, PhD

(BELG J HEMATOL 2021;(7):288-9)

Read more

Is microfilaria a transfusion transmissible disease?

BJH - volume 11, issue 7, november 2020

P. Zachée MD, PhD

SUMMARY

Due to intensive travel connections and global warming, it is possible that the vector adapts to the climatic environment of the northern half-front and that an initially tropical infectious disease becomes an emerging infectious disease in European countries. For this reason, we raise the question in the Belgian Hematology Society journal: Is microfilaria a transfusion transmissible disease? The answer is no.

(BELG J HEMATOL 2020;11(7):282-5)

Read more

O.6 Multipotent mesenchymal stromal cells for poor graft function after allogeneic hematopoietic cell transplantation – a multicenter prospective study

BJH - volume 11, issue Abstract Book BHS, february 2020

S. Servais MD, PhD, prof. F. Baron , C. Lechanteur PhD, E. Baudoux MD, A. Briquet PhD, D. Selleslag MD, J. Maertens MD, PhD, X. Poiré MD, PhD, W. Schroyens MD, PhD, C. Graux MD, PhD, A. De Becker MD, R. Schots MD, PhD, P. Zachée MD, PhD, A. Ory , J. Herman , T. Kerre MD, PhD, Y. Beguin MD, PhD

Read more

PP45 Blood transfusion in Sickle Cell Disease. Retrospective study in ZNA Hospitals (Antwerp)

BJH - 2018, issue Abstract Book BHS, february 2018

T. Eyckmans MD, S. Mahieu , M.P. Emonds MD, PhD, E. Lazarova , P. Vandenberghe MD, PhD, P. Zachée MD, PhD

Read more

O.5 Sequential administration of 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT): an interim analysis from the Belgian Hematology Society (BHS)

BJH - volume 8, issue Abstract Book BHS, february 2017

X. Poiré MD, PhD, C. Graux MD, PhD, A. Ory , J. Jamart , F. Frédéric , H. Schoemans MD, PhD, P. Lewalle MD, PhD, A. De Becker MD, D. Deeren , Z. Berneman MD, PhD, T. Kerre MD, PhD, P. Zachée MD, PhD, D. Selleslag MD, Y. Beguin MD, PhD

Read more

O.1 Infusion of mesenchymal stem cells (MSC) as treatment for steroid refractory acute graft-versus-host study (aGVHD): a multicenter prospective phase II study of the BHS

BJH - volume 7, issue Abstract Book BHS, january 2016

S. Servais MD, PhD, D. Selleslag MD, J. Maertens MD, PhD, L. Lechanteur , E. Baudoux MD, P. Zachée MD, PhD, H. Schouten , L. Noens MD, PhD, P. Lewalle MD, PhD, W. Schroyens MD, PhD, A. Ory , Y. Beguin MD, PhD

Read more

P4.10 The Ponatinib Named Patient Programme (NPP): Real-life Data from Belgian Patients

BJH - volume 7, issue Abstract Book BHS, january 2016

L. Knoops MD, PhD, G. Verhoef MD, PhD, Z. Berneman MD, PhD, D. Selleslag MD, N. Straetmans MD, PhD, L. Noens MD, PhD, P. Lewalle MD, PhD, M. André MD, PhD, D. Pranger MD, P. Zachée MD, PhD, E. Strobbe , L.J. McGarry , T. Devos MD, PhD

Read more
X